e-Drug3D 849 |
KETOTIFEN
|
cas 34580-13-7 |
CLASS RESPIRATORY |
ROUTE (list) OPHTHALMIC |
PK parameters F 60 PERCENT |
Target TARGET HISTAMINE H1 RECEPTOR |
DrugCentral Histamine H1 receptor UNIPROT P35367 HRH1 |
Download SDF file | 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)- Formula: Calculated chemical properties: MW 309.42 NB_atoms 22 XLogP 4.01 PSA 23.229 NB_HD 0 NB_HA 2 fsp3 0.32 Lipinski(0=no;1=yes) 1 |
FDA NDA 021066 (label) INN (KETOTIFEN FUMARATE) ZADITOR (ALCON PHARMA) APPROVAL= AP YEAR= 1999 NEWMOLECULARENTITY DISCONTINUED NDA 021996 (label) INN (KETOTIFEN FUMARATE) ALAWAY (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2006 NDA 077354 (pdf not found) INN (KETOTIFEN FUMARATE) KETOTIFEN FUMARATE (APOTEX INC) APPROVAL= AP YEAR= 2006 DISCONTINUED NDA 077958 (pdf not found) INN (KETOTIFEN FUMARATE) KETOTIFEN FUMARATE (SENTISS) APPROVAL= AP YEAR= 2007 NDA 077200 (pdf not found) INN (KETOTIFEN FUMARATE) ZADITOR (ALCON PHARMS LTD) APPROVAL= AP YEAR= 2008 NDA 204059 (pdf not found) INN (KETOTIFEN FUMARATE) KETOTIFEN FUMARATE (UNICHEM) APPROVAL= AP YEAR= 2020 NDA 208158 (pdf not found) INN (KETOTIFEN FUMARATE) ALAWAY (BAUSCH AND LOMB INC) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 022388 (label) INN (KETOTIFEN FUMARATE) ACUVUE THERAVISION WITH KETOTIFEN (JOHNSON JOHNSON VISN) APPROVAL= AP YEAR= 2022 DISCONTINUED |
Other links: |